Metrics as of 10/17/2026, 07:38 AM (Berlin time), refresh in progress.
Baxter International Stock
Baxter International Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Andrew Hider
- Employees
- 37,500
- Market cap
- $13.1 B
- IPO
- 27/10/1981
Baxter International Inc. is a global healthcare company headquartered in Deerfield, Illinois. Established in 1931, the company develops and provides a wide spectrum of medical products and services. Its comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Baxter International stock: price history
1D
-1.9%
1W
+3.8%
1M
+7.4%
6M
+35.1%
YTD
+32.3%
1Y
+10.1%
2Y
-31.2%
5Y
-68.3%
10Y
-46.7%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~149% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Baxter International stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Baxter International is a global provider of medical products and healthcare services. Its portfolio encompasses specialized solutions for dialysis, intravenous therapies delivered via infusion pumps, and pharmaceutical products such as oncologics and anesthetics. The company also offers surgical instruments, biological products for wound healing, and nutritional therapies. A key component of its business model consists of integrated care solutions that enable comprehensive diagnosis and treatment through the integration of hardware, software, and communication technology. Distribution takes place across more than 100 countries via direct sales, distributors, or pharmacies to facilities such as hospitals, specialty centers, and home care providers.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Baxter International
Analyst assessment of Baxter International
PRICE TARGET LOW
US$20.00
CONSENSUS
US$23.60
MEDIAN
US$24.00
PRICE TARGET HIGH
US$28.00
0
STRONG BUY
15
BUY
20
HOLD
1
SELL
0
STRONG SELL
36
TOTAL · Hold
As of: 05/10/2026
Baxter International stock metrics
P/E
-12.4
P/B
2.11
EV/EBITDA
27.45
RETURN ON EQUITY
2.0%
NET MARGIN
4.3%
DEBT/EQUITY
1.56
DIVIDEND YIELD
0.2%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.4%
FLOAT SHARES
513,695,498
AVG. DAILY VOLUME (30D)
6,487,670
Insider transactions (SEC)
Teaff James
Hider Andrew P.
Foster Julie
Teaff James
Wallace Steven P.
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.9%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Baxter International stock
What does Baxter International do?
Baxter International Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Andrew Hider, the company employs around 37,500 people.
The IPO was on 27/10/1981; the stock trades on NYSE under the ticker BAX.
What do analysts say about Baxter International stock?
36 analysts rate the stock, the consensus is Hold (as of 05/10/2026).
The average price target is US$23.60, ranging from US$20.00 to US$28.00, with a median of US$24.00.
This is an external assessment, not a statement by Market Jury.
When does Baxter International report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 149% stronger than usual.
Does Baxter International pay a dividend?
Yes. The last dividend was US$0.01 per share, ex-date 28/08/2026, paid on 01/10/2026.
The dividend yield is 0.2% (as of 30/06/2026).
Which stocks are comparable to Baxter International?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Cooper Companies, Avantor and Repligen.
How can I get Baxter International stock analyzed?
Clicking "Analyze stock" lets five strategies assess Baxter International against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.